Ratio Examination: Biohaven Ltd (BHVN)’s Price-to-Cash and Price-to-Free Cash Flow

Ulysses Smith

Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.

In the latest session, Biohaven Ltd (NYSE: BHVN) closed at $17.36 up 4.20% from its previous closing price of $16.66. In other words, the price has increased by $4.20 from its previous closing price. On the day, 2.88 million shares were traded. BHVN stock price reached its highest trading level at $18.03 during the session, while it also had its lowest trading level at $16.68.

Ratios:

For a deeper understanding of Biohaven Ltd’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.82 and its Current Ratio is at 3.82. In the meantime, Its Debt-to-Equity ratio is 2.17 whereas as Long-Term Debt/Eq ratio is at 2.13.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of. The stock’s future direction. In the most recent recommendation for this company, Citigroup on September 17, 2025, initiated with a Buy rating and assigned the stock a target price of $28.

On September 03, 2025, Raymond James started tracking the stock assigning a Strong Buy rating and target price of $75.

RBC Capital Mkts Downgraded its Outperform to Sector Perform on May 19, 2025, while the target price for the stock was maintained at $21.

Insider Transactions:

Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Mar 04 ’25 when CHILDS JOHN W bought 32,700 shares for $30.47 per share. The transaction valued at 996,238 led to the insider holds 2,320,571 shares of the business.

CHILDS JOHN W bought 29,000 shares of BHVN for $1,042,393 on Dec 30 ’24. The Director now owns 2,368,741 shares after completing the transaction at $35.94 per share.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BHVN now has a Market Capitalization of 1836531840 and an Enterprise Value of 1465996160.

Stock Price History:

The Beta on a monthly basis for BHVN is 3.38, which has changed by -0.6773819 over the last 52 weeks, in comparison to a change of 0.14201736 over the same period for the S&P500. Over the past 52 weeks, BHVN has reached a high of $54.98, while it has fallen to a 52-week low of $12.79. The 50-Day Moving Average of the stock is 15.36%, while the 200-Day Moving Average is calculated to be -21.75%.

Shares Statistics:

For the past three months, BHVN has traded an average of 2.23M shares per day and 2232060 over the past ten days. A total of 105.78M shares are outstanding, with a floating share count of 92.38M. Insiders hold about 12.68% of the company’s shares, while institutions hold 82.78% stake in the company. Shares short for BHVN as of 1759190400 were 10954186 with a Short Ratio of 4.91, compared to 1756425600 on 10645888. Therefore, it implies a Short% of Shares Outstanding of 10954186 and a Short% of Float of 11.64.

DwinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.